The Perlmutter Cancer Center at New York City-based NYU Langone Health recently launched its new Center for Molecular Oncology, naming Shridar Ganesan, MD, PhD, as director. The center will manage, ...

In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options ...

If you are one of the millions of women identified as having dense breasts, your health care team may recommend supplemental or additional screening to check your breasts for cancer.

Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting ...

Breakthroughs in laboratory and data science are increasing interest in blood tests to screen for cancer, with colorectal ...

A multi-institutional team of scientists has developed a free, publicly accessible resource to aid in classification of patient tumor samples based on distinct molecular features identified by The ...

Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the expanded commercial availability of the NavDx test for Molecular Residual Disease (MRD) ...